{"gao_id": "GAO-22-106087", "published": "2022-06-15T12:00:00Z", "released": "2022-06-15T08:00:00Z", "summary": "Federal efforts to prevent, respond to, and recover from drug misuse have been on our High Risk list since 2021. We testified about our preliminary observations on the Office of National Drug Control Policy's 2022 National Drug Control Strategy. The strategy is intended to reduce illegal drug supplies and demand; and promote prevention, early intervention, treatment, and recovery. Our preliminary review of the available documents...", "title": "Drug Policy: Preliminary Observations on the 2022 National Drug Control Strategy", "topics": ["Crisis", "Federal funds", "Data collection", "Drug control", "Substance abuse", "Deaths", "Drug overdose", "Counternarcotics", "Justice and Law Enforcement", "Prescription drugs", "Illicit drugs"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-22-106087", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-22-106087-highlights.pdf"}, {"title": "Full Report (19 pages)", "url": "https://www.gao.gov/assets/gao-22-106087.pdf"}, {"title": "Accessible PDF (20 pages)", "url": "https://www.gao.gov/assets/730/723470.pdf"}]}